Clinical Trial

Registry of Local Recurrences After Breast-conserving Surgery

Study acronym: R_ReLoCC
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 19, 2023 (before its estimated December 2024 completion). Its status may not reflect the trial's current state.
Summary
The ReLoCC project is a prospective, multicenter, clinical study to register cases of local recurrence after breast-conserving surgery, in centers dedicated to the treatment of breast cancer, in Portugal and Spain. The comparison of the results obtained will allow the optimization of the treatment, making it increasingly personalized.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-06-01; most recent amendment 2023-10-18.
Trial Details
NCT Number NCT05406661
Lead Sponsor Universidade do Porto
Collaborators: Centro Hospitalar De São João, E.P.E.
Conditions Breast Cancer Recurrent
Enrollment 3,000 participants
Start Date 2023-12-01
Primary Completion 2024-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2023-10-19